We combine deep market expertise with a personalized approach to help you achieve your financial goals.
Our platform is built for speed, scalability compliance, ensuring smooth transactions across every channel. With transparent pricing, seamless integrations, a dedicated support.
Personalized Investment Strategies
We understand that every investor’s goals, risk tolerance, and financial situation are unique we create custom-tailored investment
Diversified Portfolio Management
We understand that every investor’s goals, risk tolerance, and financial situation are unique we create custom-tailored investment
Advanced Risk Management
We understand that every investor’s goals, risk tolerance, and financial situation are unique we create custom-tailored investment
Regular Performance Reporting
We understand that every investor’s goals, risk tolerance, and financial situation are unique we create custom-tailored investment
Chronic illness rarely has a single cause — and that's precisely why it's so poorly served by conventional medicine, which excels at single-mechanism treatments. CIRS, autoimmune conditions, Long COVID, and chronic fatigue share a common biological signature: immune dysregulation, gut permeability, mitochondrial failure, and neuroinflammation. Peptide therapy is one of the few approaches that can address all four simultaneously.
Patients presenting with chronic health complaints are estimated to have a CIRS component — making it one of the most widespread and underdiagnosed conditions in functional medicine
65M+
People globally are estimated to be living with Long COVID symptoms — many sharing the same immune dysregulation and mitochondrial dysfunction signature as CIRS
~25M
Americans have an autoimmune condition — a number that has tripled in the last 40 years, tracking with rises in gut permeability and environmental biotoxin exposure
The Core Framework
The Four Shared Drivers of Chronic Illness
Different diagnoses, same upstream biology. Understanding what these conditions share is the key to treating them effectively.
The most frustrating aspect of chronic illness for most patients is being told their tests are "normal" when they clearly feel anything but. CIRS, Long COVID, autoimmune flares, and chronic fatigue syndrome don't always show up on standard labs. But they share four measurable biological patterns that functional medicine practitioners — and increasingly mainstream researchers — are learning to identify and address.
The first is immune dysregulation — the immune system responding to the wrong things at the wrong intensity. In CIRS, this is driven by biotoxin exposure (mold, Lyme, viral antigens) triggering a stuck inflammatory response. In autoimmune conditions, the immune system has begun attacking self-tissue. In Long COVID, viral immune activation persists months after the infection resolves. The common thread is an immune system that has lost its calibration.
The second is gut permeability — which feeds the immune dysregulation by continuously introducing bacterial fragments (LPS) into the bloodstream. The third is mitochondrial dysfunction — producing the fatigue, brain fog, and physical exhaustion that define every chronic illness presentation. The fourth is neuroinflammation — the brain's glial cells stuck in an activated state that impairs cognition, mood, and autonomic function.
Why Conventional Medicine Struggles with Chronic Illness
Conventional medicine excels at acute conditions with clear single-mechanism causes. Chronic illness is a multi-system failure with no single mechanism — which is why patients often see multiple specialists, none of whom can address the full picture. Peptide therapy's value in this space is precisely its multi-target reach: Thymosin Alpha-1 for immune recalibration, KPV for α-MSH restoration, BPC-157 for gut healing, SS-31 for mitochondrial repair, and Epithalon for sleep restoration — each addressing a different driver simultaneously.
🛡️
Immune Dysregulation
→ Thymosin Alpha-1 + KPV
Bidirectional immune modulation — Thymosin Alpha-1 raises underactive immune response while calming overactive components. KPV restores α-MSH levels depleted by biotoxin exposure, addressing MARCONS antimicrobial function and cytokine regulation.
🌿
Gut Permeability
→ BPC-157 + KPV
Tight junction repair and mucosal anti-inflammation — stopping the LPS-driven immune activation that perpetuates the chronic illness inflammatory loop. Without gut healing, immune recalibration is constantly undermined by a new source of immune triggers.
⚡
Mitochondrial Dysfunction
→ SS-31 + Methylene Blue
The fatigue and brain fog that define chronic illness are mitochondrial symptoms. SS-31 repairs the inner mitochondrial membrane. Methylene Blue restores electron transport chain efficiency. Together they address the energy crisis at the cellular level.
🧠
Neuroinflammation
→ Selank + Epithalon
Chronic glial activation produces brain fog, mood instability, and cognitive impairment. Selank's neuroprotective mechanism addresses the neuroinflammatory dimension. Epithalon restores the glymphatic clearance during deep sleep that removes neuroinflammatory waste overnight.
The CIRS Cascade — From Biotoxin Exposure to Systemic Dysfunction
The CIRS cascade runs from biotoxin/pathogen exposure through α-MSH depletion and TGF-β1 elevation to multi-system failure. Peptide therapy intervenes at every stage — but requires the full protocol duration to produce durable restoration.
Condition Guides in This Category
Chronic Illness Conditions We Cover
Research-backed guides for each condition — with full protocols, lab frameworks, and provider conversation scripts.
Chronic Illness · Priority #3 · Live ✓
Chronic Inflammation & CIRS
Anchor: Thymosin Alpha-1 + KPV
The most clinically detailed guide in our library. Covers the full CIRS mechanism — MARCONS, α-MSH depletion, TGF-β1 elevation — the five-peptide protocol in order, the essential labs to run before starting (TGF-β1, α-MSH, C4a), and the critical 4-month KPV protocol note that is the most common clinical error. Includes the Dr. Ritchie Shoemaker Biotoxin Illness framework.
ME-CFS is increasingly understood as a post-viral mitochondrial condition — the same energy crisis mechanism that underlies Long COVID, but often triggered years earlier. This guide covers post-exertional malaise as a mitochondrial signal, the SS-31 + BPC-157 repair protocol, pacing strategy during recovery, and why pushing through fatigue worsens rather than improves ME-CFS outcomes.
Long COVID shares significant biological overlap with CIRS — gut permeability, immune dysregulation, neuroinflammation, and mitochondrial dysfunction are all documented. Covers the post-viral gut healing protocol, Thymosin Alpha-1 for immune rebalancing, SS-31 + Methylene Blue for the mitochondrial energy crisis, and Epithalon for the disrupted sleep and circadian rhythm common in Long COVID.
Autoimmune conditions — rheumatoid arthritis, lupus, Hashimoto's, MS, and others — share a common feature: an immune system that has lost its self-tolerance. Thymosin Alpha-1 is the only peptide with documented bidirectional immune modulation. Covers the gut-autoimmune connection, molecular mimicry, the TAlpha-1 + BPC-157 protocol, and working alongside rheumatologists and immunologists.
Cross-category connections:Gut Health & Immunity covers the gut permeability and KPV mechanisms in depth. Cognitive Enhancement shares the mitochondrial SS-31 and Methylene Blue protocol — brain fog is a core chronic illness symptom. Mental Health & Mood covers the neuroinflammatory mood dimension that accompanies most chronic illness presentations.
The Peptide Stack
Peptides Used in Chronic Illness
Five peptides addressing the four shared drivers — immune dysregulation, gut permeability, mitochondrial failure, and neuroinflammation — at once.
Thymosin Alpha-1
★ Immune Modulation Anchor
Thymus-derived immune regulator with bidirectional modulation — raises underactive immune responses and calms overactive ones. The anchor peptide for CIRS, Long COVID, and autoimmune protocols. Works alongside low-dose naltrexone. Requires physician oversight and TGF-β1 monitoring.
Profile
KPV
α-MSH Restoration
Tripeptide fragment of α-MSH — directly restores the melanocyte-stimulating hormone depleted by biotoxin exposure. Antimicrobial against MARCONS. Anti-inflammatory in gut mucosa. Must be run for a minimum of 4 months without cycling off — the most critical protocol compliance point in CIRS treatment.
Profile
BPC-157
Gut Barrier Foundation
Repairs the gut permeability that continuously feeds immune activation with LPS. Oral BPC-157 is the first intervention in most chronic illness protocols — without gut healing, immune recalibration is constantly undermined by a new source of immune triggers. Also supports the vagal tone that regulates autonomic dysfunction.
Full Profile
SS-31
Mitochondrial Repair
Concentrates in the inner mitochondrial membrane, protects cardiolipin, and reduces oxidative stress at the site of ATP production. Addresses the cellular energy crisis that produces the fatigue defining every chronic illness presentation. Available as subcutaneous injection or nasal spray.
Profile
Epithalon
Sleep & Glymphatic Clearance
Chronic illness patients almost universally have disrupted restorative sleep — and poor sleep perpetuates the neuroinflammation and immune dysregulation driving their symptoms. Epithalon restores deep sleep and activates the glymphatic clearance that removes neuroinflammatory waste overnight. Near-universal inclusion in chronic illness protocols.
Full Profile
"CIRS is a disease of lost regulatory control — the immune system can't turn off because the signal to stop was removed. KPV restores that signal. Thymosin Alpha-1 resets the responder. Together they're addressing the mechanism, not just the symptoms."
Where to Start
The Chronic Illness Protocol — In Order
Sequencing is critical in chronic illness — each layer depends on the previous one. This is not a protocol to rush.
Step 0 — Labs First
No chronic illness protocol should begin without the right labs. CIRS-specific markers: TGF-β1 (primary immune dysregulation marker), α-MSH, C4a, MMP-9, VEGF, and a MARCONS culture (nasal swab). General: hsCRP, IGF-1, comprehensive metabolic panel, gut inflammatory markers (fecal calprotectin). These labs determine which peptides are most needed and provide the baseline to track against. Flying blind on chronic illness is the most common reason protocols fail.
Step 1 — Gut Foundation
Oral BPC-157 before immune peptides. Healing gut permeability first removes the continuous LPS-driven immune activation that will otherwise undermine Thymosin Alpha-1 and KPV. 250–500 mcg/day on empty stomach. Give it 2–4 weeks before adding immune peptides. This sequencing — gut before immune — is the most important structural principle in chronic illness protocols.
Step 2 — KPV + Thymosin A1
The immune recalibration layer — after gut foundation is established. KPV oral 500 mcg–1 mg/day for a minimum 4 months without cycling off. Thymosin Alpha-1 0.5–1.6 mg subcutaneous, 2–3x per week, under physician supervision with TGF-β1 monitoring. These two peptides together address the α-MSH depletion and immune dysregulation at the center of CIRS. Patience is required — immune recalibration is measured in months, not weeks.
Step 3 — Mitochondrial Layer
SS-31 for the energy crisis driving fatigue and brain fog. Nasal spray for brain-targeted delivery; subcutaneous injection for systemic benefit. For most chronic illness presentations, Methylene Blue is added in this layer as well — providing the acute mitochondrial ATP boost that SS-31's structural repair doesn't offer immediately. These two work in sequence: Methylene Blue for rapid energy restoration, SS-31 for durable structural repair.
Step 4 — Sleep Restoration
Epithalon for the neuroinflammatory sleep debt. A 10-day Epithalon course restores deep sleep and activates glymphatic clearance — the brain's overnight waste removal system that chronic illness patients have typically been running at a deficit for months or years. Sleep improvement is often one of the first tangible signs of protocol progress and should be actively monitored as a proxy for overall recovery trajectory.
Step 5 — Reassess Labs
Recheck TGF-β1, α-MSH, and inflammatory markers at 3–4 months. These lab changes are the objective measure of protocol effectiveness — not subjective symptom improvement alone. TGF-β1 should be falling toward normal range; α-MSH should be rising. If progress is insufficient, adjust doses and timing under physician guidance. Chronic illness recovery is a non-linear process — expect variation and monitor the trend, not individual data points.
Free Resource
Get the Chronic Illness Peptide Primer
A free starter guide covering the CIRS labs to order, how to read your TGF-β1 result, the KPV 4-month protocol explained, and the foundations checklist — before your first provider conversation.
